#TNXP Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®

#TNXP Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Tonix Pharmaceuticals (NASDAQ: TNXP) promotes Thomas Englese to Chief Commercial Officer to lead growth of TONMYA, the first new fibromyalgia treatment in 15+ years, plus its migraine portfolio. #Biopharma #TNXP
#TNXP Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
🚀 Zacks Small Cap Research - TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-tnxp-11-0-million-in-tonmya-net-revenue-in-2q26/
#TonixPharma #Tonmya #TNXP #Tonix #LymeDisease #TNX4800 #OspA #LymeProphylaxis #MDD